BIOLASE Inc
NASDAQ:BIOL
BIOLASE Inc
Net Income (Common)
BIOLASE Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BIOLASE Inc
NASDAQ:BIOL
|
Net Income (Common)
-$37.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-13%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
106%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is BIOLASE Inc's Net Income (Common)?
Net Income (Common)
-37.6m
USD
Based on the financial report for Dec 31, 2023, BIOLASE Inc's Net Income (Common) amounts to -37.6m USD.
What is BIOLASE Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-13%
Over the last year, the Net Income (Common) growth was -30%. The average annual Net Income (Common) growth rates for BIOLASE Inc have been -3% over the past three years , -12% over the past five years , and -13% over the past ten years .